3Bone R. Immunology dissonance: a continuing evolution in our understanding of the systemic Inflammatory response syndromes and the multiple organ dysfunction syndrome. Ann Int Med,1996, 125: 680-687.
4Kahama H, Kuribayashi K, Susita M, et al. Cytoprotective effect of ulinastatin, a kunitztype protease inhibitor, on hypoxic injury in L-2 cells treated with antimycin A via stabilization of lysosomal fragility. Pulm Pharmacol Ther. 1999, 12: 1-6.
5Kawamura T, Inada K, Akasaka N, Wakusawa R. Ulinastain reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth. 1996, 43: 456-460.
6Ambiru S, Miyazaki M. Effects of perioperative protease inhibitor on inflammatory cytokines and acute-phase proteins in patients with hepotic resection. Dig Sury. 2000, Vol. 17: 337-343.
7Bed AL, Lerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA,1994, 271: 226-233.
二级参考文献5
1Yuman F,Moldawer L,Marano M,et al.Tumor necrosis factor in the pathophysiology of infection and sepsis[].Clinical Immunology.1990
2Walter L,Emest E,Frederick A,et al.Interleukin-6 in the injured patient[].Annals of Surgery.1996
3Hack CE,Hart M,Strack van Schijndel KJM,et al.IL-8 in sepsis:relation to shock and inflammatory mediators[].Infection and Immunity.1992
4Yao YM,Sheng CY,Yan Y,et al.The potential etiologic role of tumor necrosis factor in dysfunction in rats following intestinal ischemia reperfusion injury[].Resuscitation.1995
5Faist E,Strock M,Hiltner L,et al.Functional annalysis of monocyte activity and through synthesis patterns of proinflammatory cytokines and neoterin in patients in surgical intensive care[].Journal of Surgery.1992
